Marie-Pier St-Laurent, George Acland, Sarah N Hamilton, Jeremy Hamm, Katherine Sunderland, Peter C Black, Michael McKenzie, Mira Keyes, Stacy Miller, Martin E Gleave, Scott Tyldesley
{"title":"接受低剂量近距离放射治疗和根治性前列腺切除术的前列腺癌患者的长期二次恶性肿瘤。","authors":"Marie-Pier St-Laurent, George Acland, Sarah N Hamilton, Jeremy Hamm, Katherine Sunderland, Peter C Black, Michael McKenzie, Mira Keyes, Stacy Miller, Martin E Gleave, Scott Tyldesley","doi":"10.1097/ju.0000000000003965","DOIUrl":null,"url":null,"abstract":"Second malignancy is a rare but potentially lethal event after prostate brachytherapy, but data remain scarce on its long-term risk. The objective of this study is to estimate the number of pelvic second malignancies following brachytherapy compared to prostatectomy (RP).","PeriodicalId":501636,"journal":{"name":"The Journal of Urology","volume":"47 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long Term Second Malignancies in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy and Radical Prostatectomy.\",\"authors\":\"Marie-Pier St-Laurent, George Acland, Sarah N Hamilton, Jeremy Hamm, Katherine Sunderland, Peter C Black, Michael McKenzie, Mira Keyes, Stacy Miller, Martin E Gleave, Scott Tyldesley\",\"doi\":\"10.1097/ju.0000000000003965\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Second malignancy is a rare but potentially lethal event after prostate brachytherapy, but data remain scarce on its long-term risk. The objective of this study is to estimate the number of pelvic second malignancies following brachytherapy compared to prostatectomy (RP).\",\"PeriodicalId\":501636,\"journal\":{\"name\":\"The Journal of Urology\",\"volume\":\"47 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/ju.0000000000003965\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ju.0000000000003965","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Long Term Second Malignancies in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy and Radical Prostatectomy.
Second malignancy is a rare but potentially lethal event after prostate brachytherapy, but data remain scarce on its long-term risk. The objective of this study is to estimate the number of pelvic second malignancies following brachytherapy compared to prostatectomy (RP).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
